SEC Company Response from WELLS FINANCIAL CORP (CIK 0000934739) — Oct 13, 2004
WELLS FINANCIAL CORP (CIK 0000934739)
Date: Oct. 13, 2004 · CIK: 0000934739 · Accession: 0000946275-04-000937
AI Filing Summary & Sentiment
Referenced dates: October 7, 2004
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
MALIZIA SPIDI & FISCH, PC
ATTORNEYS AT LAW
1100 NEW YORK AVENUE, N.W. 1900 SOUTH ATHERTON STREET
SUITE 340 WEST STATE COLLEGE, PENNSYLVANIA 16801
WASHINGTON, D.C. 20005 (814) 272-3502
(202) 434-4660 FACSIMILE: (814) 272-3514
FACSIMILE: (202) 434-4661
JOHN J. SPIDI WRITER'S DIRECT DIAL NUMBER
SPIDI@MALIZIALAW.COM (202) 434-4670
VIA EDGAR
---------
October 13, 2004
Abby Adams, Esq.
Special Counsel
Office of Mergers and Acquisitions
Securities and Exchange Commission
450 5th Street, N.W.
Washington, D.C. 20549
Re: Wells Financial Corp.
Schedule TO and Schedule 13E-3
SEC File No. 5-45455
--------------------
Dear Ms. Adams:
Transmitted with this letter for filing with the Commission on behalf
of the above-referenced registrant are manually executed copies of Amendment
No. 1 to the registrant's Tender Offer Statement on Schedule TO and Schedule
13E-3 Transaction Statement.
On behalf of Wells Financial Corp. (the "Company"), we hereby submit
the following responses to your comment letter dated October 7, 2004, with
respect to the above-referenced filings. We have keyed our responses to the
captions and paragraph numbering used in your comment letter.
Schedule 13E-3
--------------
1. In accordance with your comment, Item 6(c) of Schedule TO has
been amended to add the incorporation by reference in paragraph
7, "Special Factors - 6. Effects of the Offer," wherein the
information required by Instruction 2 to Item 1013 of Regulation
M-A is required. Please see the disclosure on pages 19 through 21
under the caption "Special Factors - 6. Effects of the Offer"
wherein the Company has disclosed the benefits and detriments of
the offer to the Company and its stockholders and has quantified
such discussion to the extent practicable. For
<PAGE>
MALIZIA SPIDI & FISCH, PC
Abby Adams, Esq.
Special Counsel
October 13, 2004
Page 2
example, in the third full paragraph on page 20 of the Offer to
Purchase, the Company has quantified the cost of maintaining its
status as a public company to be approximately $440,000 per year.
One benefit of the offer, if the Company is able to deregister as
a result of the offer, will be the elimination of such expense.
Additional benefits to the Company and its stockholders, as well
as the detriments of the offer, are also disclosed throughout
this section of the Offer to Purchase.
2. The Company has this day filed an amendment to its Schedule TO
and Schedule 13E-3 with the Commission on EDGAR which include
responses to the staff's comments. The Company believes this is
adequate and prompt dissemination of the revised information. The
new information occasioned by the staff's comments is immediately
available to all stockholders of the Company via the Internet on
the Commission's website. We are aware of similar circumstances
where the staff has concurred with this method of dissemination.
In addition, it appears that Rule 13e- 4(e)(3)(iv) requires the
offer to remain open for an additional 20 business days only in
the case of a registered securities offering wherein the initial
prospectus was materially deficient. The Company's offer is not a
registered securities offer but rather an offer to purchase for
all cash and a prospectus was not utilized. Therefore, the
Company does not believe it is required to keep the offer open
for 20 business days after dissemination of the revised
information. In addition, the Company is not required to keep the
offer open for any additional period as there has not been a
material change in the terms of the offer as set forth in Rule
13e- 4(f)(1)(ii) .
Offer to Purchase
-----------------
Cover Page
----------
3. We have added the legend required by Rule 13e-3(e)(1)(iii) to the
amended Schedule TO pursuant to your comment.
Summary
-------
4. We have made the requested change to "Item 1. Summary Term Sheet"
of Amendment No. 1 to the Schedule TO filed herewith.
<PAGE>
MALIZIA SPIDI & FISCH, PC
Abby Adams, Esq.
Special Counsel
October 13, 2004
Page 3
Background of the Offer, page 7
-------------------------------
5. We have revised the Offer to Purchase to indicate that the June
15, 2004 analysis presented to the Board related to a possible
reverse stock split rather than to an issuer tender offer. Since
such analysis did not materially relate to the transaction, we do
not believe it is required to be filed as an exhibit. We wish to
advise the staff supplementally that, to the Company's best
knowledge, there are no additional reports, opinions or
appraisals of the kind required to be disclosed and summarized by
Item 1015 of Regulation M-A. Please note that Capital Resources'
final valuation analysis dated September 21, 2004, has been
summarized on pages 9 and 10 and pages 12 through 14 of the Offer
to Purchase and was filed with the Commission as Exhibit (c)(2)
to the Schedule TO. As is summarized on page 8 of the Offer to
Purchase, the Board of Directors did receive presentations from
the Company's Minnesota counsel and independent auditors
regarding the Company's status as a public company, the legal and
accounting requirements of the Sarbanes- Oxley Act of 2002 and
the various legal consequences and alternatives to deregistering
the Company's stock from the Nasdaq Stock Market and the
reporting requirements of the Exchange Act. We do not believe
these presentations, which are fully summarized in the Offer to
Purchase, are reports, opinions or appraisals required to be
filed as exhibits to the Schedule 13E-3 pursuant to Item 1016(c)
of Regulation M-A as they do not materially relate to the
consideration or the fairness of the offer to the Company or its
stockholders. Rather, these presentations discuss mainly legal
and accounting requirements imposed on the Company by the
Exchange Act and the alternative procedures and methods for
terminating such requirements.
6. Please see the revised disclosure under the caption "Schedule
13e-3, Item 8(b). Fairness of Transaction" wherein additional
disclosure has been added concerning the non-public information
furnished to the Company's financial advisor. We wish to advise
the staff supplementally that the "loan schedules, non-performing
assets, investment securities, deposit and borrowing schedules"
referred to in item (v) on page 15 of the Offer to Purchase, as
referenced in your comment, consist of publicly available
information derived from the Company's Thrift Financial Report
filed with the Office of Thrift Supervision ("OTS"). Such
information, which is also routinely disclosed in the Company's
periodic reports filed with the Commission, is available to the
public on the OTS website at www.ots.treas.gov. Consequently, the
-----------------
only non-public information furnished to the Company's
<PAGE>
MALIZIA SPIDI & FISCH, PC
Abby Adams, Esq.
Special Counsel
October 13, 2004
Page 4
financial advisor was the Company's business plan and budget
which contained the financial projections disclosed under
"Special Factors -- 4. Fairness Opinion of Financial Advisor" on
pages 14 through 18 of the Offer to Purchase and in the Valuation
Analysis dated September 21, 2004, filed as Exhibit (c)(2) to the
Schedule TO. In particular, we wish to direct your attention to
the disclosure on pages 17 and 18 of the Offer to Purchase under
the subcaption "Discounted Cash Flow and Terminal Value Analysis"
and to Table 3 in the Valuation Analysis where all the non-public
financial forecasts and projections furnished to Capital
Resources are disclosed. In both places, disclosure has been made
regarding the assumptions for growth in net income and dividend
rates, price to earnings multiples, rates of return, trading
prices and present and terminal values of the foregoing. The
Company does not generally make these forecasts and projections
public.
7. Please see the revised disclosure to Amendment No. 1 to the
Schedule TO under the caption "Item 6. Purposes of the
Transaction and Plans or Proposals."
Purposes of and Reasons for the Offer, page 10
----------------------------------------------
8. Please see the third full paragraph on page 20 of the Offer to
Purchase under the caption "Special Factors -- 6. Effects of the
Offer." wherein the Company estimates that deregistering from
reporting under the Exchange Act and listing on the Nasdaq Stock
Market will save it approximately $440,000 per year as result of
reduced legal fees, accounting fees, transfer agent fees, Nasdaq
listing fees and expenses associated with communicating with its
stockholders. We believe that this disclosure is more
appropriately included in the section of the Offer to Purchase
that covers the effects the offer will have on the Company.
9. We believe that the potential for proration in the offer is
adequately disclosed both in the Summary Term Sheet (page 2,
second question) and throughout the body of the Offer to Purchase
(pages 24, 26, 28, 29, 35, 36 and 37). In addition, the
disclosure in the second paragraph on page 11 of the Offer to
Purchase states that stockholders, who because of the size of
their holdings may not be able to sell their shares without
disruption to the share price, will be provided with an
opportunity to obtain liquidity with respect to their shares
without potential disruption to the share price. Moreover, the
disclosure regarding avoiding the usual transaction costs
associated with a market sale is accurate even in the event
<PAGE>
MALIZIA SPIDI & FISCH, PC
Abby Adams, Esq.
Special Counsel
October 13, 2004
Page 5
of significant proration. The referenced disclosure makes no
representation, and does not imply, however, that large
stockholders will be fully cashed-out in the offer.
Fairness of the Offer, page 12
------------------------------
10. Please see the revised disclosure in "Item 8. Fairness of
Transaction" in Amendment No. 1 to the Schedule 13E-3 wherein we
have revised the second paragraph under "Special Factors - 3.
Fairness of the Offer" to clarify that the factors listed
thereunder are all of the factors taken into account by the Board
of Directors in support of its determination that the offer is
fair and in the best interests of stockholders.
11. Please see the revised disclosure on page 5 of Amendment No. 1 to
the Schedule TO under the caption "Special Factors - 3. Fairness
of the Offer" wherein the disclosure regarding the factors has
been augmented in accordance with your comment.
12. Wells Federal Bank, fsb (the "Bank") is a wholly-owned subsidiary
of the Company and is not an "offeror," "third party bidder" or
"other person" required to be included as a filing person on the
Company's Schedule TO. General Instruction K(1) of Schedule TO
defines an offeror as "any person who makes a tender offer or on
whose behalf a tender offer is made." Rule 13e-4(a)(2) defines an
"issuer tender offer" as a "tender offer for .... any class of
equity security, made by the issuer of such class of equity
security or by an affiliate of such issuer." In our case, the
tender offer is being made by the Company, not the Bank or on
behalf of the Bank, and it is being self-financed by the Company.
We are aware of numerous similar transactions filed with the
Commission under exactly the same or similar circumstances where
subsidiaries of bank and thrift holding companies were not deemed
"filing persons" by the Commission. In addition, wholly-owned
subsidiaries of issuers are not defined by Rule 13e-4 or
Regulation 14D as "offerors" or "third party bidders." In the
Company's tender offer, the Bank is a functioning business
subsidiary that was not created as an acquisition subsidiary or
otherwise to facilitate the tender offer in any way. In fact, the
Bank has been in existence as a functioning business since 1934.
While the funds to complete the acquisition of the Company's
stock were derived from the repayment to the Company of a loan
from the Company to the Bank, it was not necessary for
<PAGE>
MALIZIA SPIDI & FISCH, PC
Abby Adams, Esq.
Special Counsel
October 13, 2004
Page 6
the Bank or any other party "to obtain financing" for the tender
offer, as a current asset of the Company, a loan receivable from
the Bank, was used. Because the Company owns 100% of the Bank,
this is merely an intra-company transfer of Company funds within
a consolidated entity (for financial reporting and tax purposes),
and should not be considered separate, third-party financing of
the tender offer. While there is substantial overlap between the
management and directors of the Bank an